Literature DB >> 27563011

MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.

Li Jin1, Jun Yi2, Yanping Gao1, Siqi Han1, Zhenyue He1, Longbang Chen3, Haizhu Song3.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is among the most aggressive malignancies and has a high incidence in China. MicroRNAs (miRNAs) are small endogenous RNAs that regulate multiple tumorigenic processes, including proliferation, invasion, metastasis and prognosis. Using miRNA expression profiling analysis, we found that miR-630 was markedly down-regulated in three ESCC tissue samples compared with that in paired normal esophageal tissues. Differential miR-630 expression was subsequently confirmed using quantitative real-time PCR. To determine whether miR-630 down-regulation could be considered as a diagnostic indicator and adverse prognostic factor, we investigated the association between miR-630 and clinicopathological characteristics in patients with ESCC. It was found that decreased miR-630 expression was associated with poor overall survival in these patients. In addition, we also explored the biological function of miR-630 by targeting Slug and investigated the correlation between miR-630 expression and epithelial-mesenchymal transition (EMT) progression in vivo and in vitro Ectopic miR-630 expression could inhibit proliferation, invasion and metastasis, whereas miR-630 knockdown induced proliferation, invasion, metastasis and EMT traits. Overall, our study supports a role for miR-630 as a critical novel modulator in ESCC.
© The Author 2016. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  epithelial–mesenchymal transition; esophageal squamous cell carcinoma; invasion and metastasis; miR-630; suppressor

Mesh:

Substances:

Year:  2016        PMID: 27563011     DOI: 10.1093/abbs/gmw073

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  13 in total

Review 1.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

2.  CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630.

Authors:  Yan Zhang; Hao Liu; Wende Li; Jiang Yu; Jin Li; Zhiyong Shen; Gentai Ye; Xiaolong Qi; Guoxin Li
Journal:  Aging (Albany NY)       Date:  2017-06-27       Impact factor: 5.682

3.  MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.

Authors:  Ming-Jenn Chen; De-Wei Wu; Gao-Chang Wang; Yao-Chen Wang; Chi-Yi Chen; Huei Lee
Journal:  Oncotarget       Date:  2018-02-09

4.  A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.

Authors:  De-Wei Wu; Yao-Chen Wang; Lee Wang; Chih Yi Chen; Huei Lee
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

5.  MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.

Authors:  Suna Zhou; Yaoyou Cui; Dequan Yu; Jun Liang; Mingxin Zhang; Wenguang Ye
Journal:  Onco Targets Ther       Date:  2017-05-11       Impact factor: 4.147

6.  Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Yanping Gao; Jun Yi; Kai Zhang; Fan Bai; Bing Feng; Rui Wang; Xiaoyuan Chu; Longbang Chen; Haizhu Song
Journal:  J Exp Clin Cancer Res       Date:  2017-11-16

7.  Claudin1 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells by upregulating the expression and nuclear entry of β-catenin.

Authors:  Xin Wu; Jianghong Xiao; Chong Zhao; Chengjian Zhao; Zhongcheng Han; Feng Wang; Yuqiong Yang; Yu Jiang; Fang Fang
Journal:  Exp Ther Med       Date:  2018-08-20       Impact factor: 2.447

8.  Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Zhen-Yong Zhang; Yue Zhang; Rong Wu
Journal:  Clin Transl Gastroenterol       Date:  2018-11-13       Impact factor: 4.488

9.  Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.

Authors:  Lingyu Kong; Zhongbing Wu; Yang Zhao; Xin Lu; Huijuan Shi; Shugang Liu; Jing Li
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

10.  Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma.

Authors:  Jun Rong; Qian Wang; Yanzhou Zhang; Daolong Zhu; Handong Sun; Weiwei Tang; Rongping Wang; Weihong Shi; Xiu-Feng Cao
Journal:  Onco Targets Ther       Date:  2018-10-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.